Drugmaker Johnson & Johnson could apply for emergency use authorization of its Janssen Covid-19 vaccine around the end of this month, Moncef Slaoui of Operation Warp Speed said during a briefing on Tuesday.
Slaoui said millions of doses should be available by the end of February.
"We are very clear – we, meaning Operation and Janssen Pharmaceuticals – that analysis will be completed before the end of the month, and EUA submission will take place at the end of this month," Slaoui said on Tuesday.
"In terms of vaccine dose availability, if submission is happening at the end of January, one could project that approval of the emergency use authorization may happen somewhere in the middle of the month of February," Slaoui added.
"We project to have single-digit million number of doses available in the second half of February," Slaoui said. "We're trying to make that number get as close to a double-digit number as possible and then a larger number in March and a much larger number in April. Remember, this is a one-shot vaccine so those are millions of individuals fully immunized."